Pancreatic cancer

August 17, 2021
Patient getting imaging

EA2185 Pancreatic Cyst Surveillance Study: Amendment #2 Highlights

This study is evaluating two different screening strategies for non-cancerous pancreatic cysts; recently activated amendment #2 expands the eligibility criteria
July 7, 2021
Older woman walking with doctor

Trial Spotlight: Efrat Dotan on the GIANT Study for Older Adults with Pancreatic Cancer

The GIANT trial (EA2186) is the first randomized clinical trial to focus on vulnerable older adults with treatment-naïve metastatic pancreatic cancer who are not candidates for standard therapy
May 28, 2021
Doctor and patient reviewing test results

Now Enrolling: EA2192/APOLLO for Pancreatic Cancer

This phase II study, led by Dr. Kim Reiss Binder, is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
July 29, 2020

Now Enrolling: EA2186 / GIANT for Advanced Pancreas Cancer in Older Adults

Currently, there is no treatment standard for metastatic pancreatic cancer in people aged 65 years and older